Prospective Single Arm CAS - ROADSAVER Study - Trial NCT03504228
Access comprehensive clinical trial information for NCT03504228 through Pure Global AI's free database. This phase not specified trial is sponsored by Terumo Europe N.V. and is currently Completed. The study focuses on Carotid Artery Stenosis. Target enrollment is 1967 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Terumo Europe N.V.
Timeline & Enrollment
N/A
Jan 23, 2018
Jun 20, 2022
Primary Outcome
The rate of Major Adverse Events (MAE)
Summary
Approximately 2000 patients eligible for elective treatment with a Carotid Stent according to
 hospital routine practice in centers across Europe will be enrolled in the study. The maximum
 number of patients enrolled at each site will be not limited. Follow-ups are scheduled at
 discharge, 30 days, and 1 year, as per local practice. Each patient will have follow-up
 contacts via hospital visit and/or telephone.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03504228
Device Trial

